• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. Back to Search Results
Catalog Number 195-160
Device Problem Use of Device Problem (1670)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/08/2023
Event Type  Injury  
Manufacturer Narrative
The remainder of the investigation remains in progress.A supplemental report will be provided after completion.Single use; device discarded.
 
Event Description
The consumer reported accidental exposure to the binaxnow covid-19 self-test reagent on (b)(6) 2023.Per the consumer, she added six drops of reagent to the test card then inserted the swab into the test card before taking her nasal sample.Realizing her error, she removed the swab from the test card (that was reportedly "dipped in reagent"), swabbed both nostrils, and re-inserted the swab into the test card.The consumer denied any burning within the nostril and reportedly took no remedial action.Additionally, she confirmed that she is "feeling good and doesn't have any discomfort".There was no reported patient impact.Additionally, the consumer reported that her test kit only contained a spanish language package insert.
 
Event Description
The consumer reported accidental exposure to the binaxnow covid-19 self-test reagent on 08jan2023.Per the consumer, she added six drops of reagent to the test card then inserted the swab into the test card before taking her nasal sample.Realizing her error, she removed the swab from the test card (that was reportedly "dipped in reagent"), swabbed both nostrils, and re-inserted the swab into the test card.The consumer denied any burning within the nostril and reportedly took no remedial action.Additionally, she confirmed that she is "feeling good and doesn't have any discomfort".There was no reported patient impact.Additionally, the consumer reported that her test kit only contained a spanish language package insert.
 
Manufacturer Narrative
A product deficiency was not reported or found.The customer refused sds and stated they are not facing any discomfort.A supplemental report will be provided if any additional information is obtained.The reported health status is anticipated in nature and severity for binaxnow covid-19 ag card risk documentation.H3 other text : single use; device discarded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG SELF TEST 2CT
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key16151539
MDR Text Key307261589
Report Number1221359-2023-00066
Device Sequence Number1
Product Code QKP
UDI-Device Identifier00811877011408
UDI-Public00811877011408
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210264
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 03/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date12/15/2023
Device Catalogue Number195-160
Device Lot Number218644
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/08/2023
Initial Date FDA Received01/12/2023
Supplement Dates Manufacturer Received03/14/2023
Supplement Dates FDA Received03/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age72 YR
Patient SexFemale
Patient Weight79 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-